80 Biggest Movers From Yesterday

Gainers

• Avenue Therapeutics, Inc. ATXI jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday.
• CTI BioPharma Corp. CTIC surged 63.2% to close at $3.10 after the company announced FDA accelerated approval of VONJO for the treatment of adult patients with myelofibrosis and thrombocytopenia.
• GBS Inc. GBS gained 50% to close at $0.69 after declining around 9% on Monday.
• Guardion Health Sciences, Inc. GHSI surged 47.8% to close at $0.28. Guardion Health Sciences, last month, priced its $11 million public offering.
• CooTek (Cayman) Inc. CTK gained 36.2% to settle at $0.3203.
• Trevi Therapeutics, Inc. TRVI surged 36.1% to close at $0.8711. Trevi Therapeutics recently announced positive interim analysis results from Phase 2 CANAL trial of Haduvio (nalbuphine ER) in idiopathic pulmonary fibrosis patients (IPF) suffering from chronic cough.
• Sky Harbour Group Corporation SKYH gained 30.8% to settle at $15.23.
• GWG Holdings, Inc. GWGH jumped 29.4% to close at $5.33.
• Avinger, Inc. AVGR jumped 28.3% to settle at $0.3336. Avinger recently reported successful completion of first cases with Lightbox 3 next generation imaging console.
• Blonder Tongue Laboratories, Inc. BDR gained 27.9% to close at $0.55. Blonder Tongue Laboratories recently announced next generation DRAKE PEG encoder line.
• UserTesting, Inc. USER shares surged 27.3% to settle at $10.59 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates.
• Mmtec, Inc. MTC gained 26.2% to close at $0.5740.
• Oak Street Health Inc OSH jumped 23.5% to close at $21.63. Oak Street reported FY21 revenue of $1.43 billion.
• Marker Therapeutics, Inc MRKR gained 22.3% to settle at $0.46.
• iQIYI, Inc. IQ shares jumped 21.5% to close at $5.03 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion.
• InVivo Therapeutics Holdings Corp. NVIV surged 21.3% to settle at $0.3702.
• Stabilis Solutions, Inc SLNG gained 20.8% to close at $5.81.
• X4 Pharmaceuticals, Inc. XFOR surged 20% to close at $1.80.
• Danimer Scientific Inc DNMR gained 19.9% to close at $4.77 following narrower-than-expected quarterly loss.
• Workhorse Group Inc. WKHS surged 19.5% to close at $3.74 after the company reported Q4 results. The company said it expects to sell at least 250 vehicles in 2022 and generate at least $25 million in revenue.
• American Rebel Holdings, Inc.  AREB jumped 18.8% to close at $1.58. American Rebel recently reported closing of $10.5 million public offering.
• Tiziana Life Sciences PLC TLSA gained 18.6% to settle at $0.7710. Tiziana Life Sciences recently highlighted submission of amendment for investigational new drug application to advance oral foralumab for Crohn's Disease.
• New Pacific Metals Corp. NEWP jumped 18.6% to close at $3.64. New Pacific Metals, last month, posted Q2 loss of $0.01 per share.
• NeuBase Therapeutics, Inc NBSE gained 18.2% to close at $1.75.
• Arcimoto, Inc FUV surged 17% to close at $6.88. Arcimoto and Susie's Mopeds, an experience rental company in Friday Harbor, Washington, plan to begin demo rentals of Arcimoto Fun Utility Vehicles on San Juan Island beginning in March.
• Ra Medical Systems, Inc.</b> RMED rose 17% to settle at $0.4998. Ra Medical Systems filed 510(k) application for the DABRA catheter with braided overjacket and six-month shelf life.
• AnPac Bio-Medical Science Co., Ltd. ANPC surged 16.9% to settle at $0.77.
• New Fortress Energy Inc.NFE gained 16.9% to close at $32.25 after the company reported better-than-expected Q4 sales results.
• Summit Therapeutics Inc. SMMT gained 16.8% to close at $3.20. Summit Therapeutics recently reported postponement of its planned rights offering.
• TaskUs, Inc. TASK gained 16.2% to close at $33.37 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
• LivePerson, Inc. LPSN rose 16% to close at $23.52. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.
• Veritiv Corporation VRTV jumped 15.6% to close at $123.92 after the company posted upbeat quarterly results.
• BP Prudhoe Bay Royalty Trust BPT rose 15.4% to close at $14.55 as the Russia-Ukraine conflict caused supply concerns.
• Redbox Entertainment Inc. RDBX surged 15.4% to close at $2.17.
• Freshpet, Inc.</b> FRPT gained 15.2% to settle at $109.74 after the company issued FY22 sales guidance above analysts’ estimates.
• AVITA Medical, Inc. RCEL gained 14.9% to close at $10.57 following Q2 results.
• Dogness (International) Corporation DOGZ surged 14.5% to close at $3.24.
• Humanigen, Inc. HGEN rose 14.3% to close at $2.32. Humanigen recently reported a FY21 net loss of $4.04 per share.
• Quantum-Si Inc QSI gained 13.5% to close at $4.72 following Q4 results.
• Cano Health, Inc. CANO rose 9.9% to close at $5.35. Cano Health delayed Q4 earnings release and conference call.
• Target Corporation TGT climbed 9.8% to close at $219.43 after the company reported better-than-expected Q4 EPS results and issued FY22 guidance.
• Ucommune International Ltd UK shares gained 8.3% to close at $0.4397 after dipping around 17% on Monday.

Check out this: Insiders Sell Around $16M Of 4 Stocks

Losers

• Vroom, Inc. VRM dropped 46.6% to settle at $3.25 after the company reported worse-than-expected Q4 EPS results.
• Mullen Automotive, Inc. MULN fell 39.1% to close at $1.03 after gaining over 145% on Monday. Mullen Automotive recently announced progress on solid-state polymer battery pack development.
• GoodRx Holdings, Inc. GDRX shares tumbled 38.9% to close at $16.74 on Tuesday after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
• Imperial Petroleum Inc. IMPP fell 37.6% to close at $1.48.
• Check-Cap Ltd. CHEK dropped 37% to settle at $0.3870 after the company announced a $10 million registered direct offering.
• ZimVie Inc. ZIMV dipped 32.8% to close at $25.53. Credit Suisse initiated coverage on ZimVie with an Underperform rating and announced a price target of $34.
• Ambarella, Inc. AMBA fell 31.3% to close at $95.98 after the company reported Q4 earnings results and issued guidance.
• Semler Scientific, Inc. SMLR dipped 27.9% to close at $52.64 after the company reported Q4 EPS and sales results down from last year.
• VEON Ltd. VEON dropped 26.3% to close at $0.38. VEON recently reported Q4 earnings results.
• DSS, Inc. DSS shares fell 23.1% to close at $0.4352 after jumping 47% on Monday.
• Endo International plc ENDP dropped 22.5% to close at $2.41 after the company reported Q4 earnings results.
• Sidus Space, Inc. SIDU fell 22% to close at $4.18.
• Atara Biotherapeutics, Inc. ATRA dropped 20.5% to close at $10.21 after the company reported worse-than-expected Q4 EPS results.
• Indonesia Energy Corporation Limited INDO dipped 20.2% to settle at $10.78.
• Zeta Global Holdings Corp. ZETA fell 19.9% to settle at $10.42.
• James River Group Holdings, Ltd. JRVR dropped 19.5% to close at $21.41 after the company reported Q4 EPS results down from last year.
• Paya Holdings Inc. PAYA fell 19.5% to close at $5.19 following Q4 results.
• China SXT Pharmaceuticals, Inc. SXTC fell 19.5% to close at $0.1730 in pre-market trading after jumping 45% on Monday.
• Intellia Therapeutics, Inc. NTLA fell 19.2% to close at $79.85. Eight months after delivering promising biomarker data from one of the first CRISPR trials, Intellia Therapeutics presented additional data from the Phase 1 trial for NTLA-2001 in transthyretin, or ATTR, amyloidosis.
• MBIA Inc. MBI dipped 19% to settle at $12.35 after the company reported worse-than-expected Q4 EPS results.
• Heron Therapeutics, Inc. HRTX dropped 18.9% to close at $5.76 after the company reported worse-than-expected Q4 sales results.
• Core Scientific, Inc. CORZ fell 18.6% to close at $7.49.
• NeuroSense Therapeutics Ltd. NRSN dropped 18.1% to close at $2.13. NeuroSense Therapeutics was granted patent for its ALS drug PrimeC in Australia.
• Vallon Pharmaceuticals, Inc. VLON dipped 17.6% to close at $6.09. Vallon Pharmaceuticals recently announced issuance of US patent covering ADAIR for treatment of cognitive impairment associated with COVID-19.
• Albireo Pharma, Inc. ALBO dropped 17.3% to settle at $27.57 after the company reported Q4 earnings results.
• PubMatic, Inc. PUBM shares fell 17.2% to close at $25.35 after the company issued Q1 sales guidance below estimates.
• Werewolf Therapeutics, Inc. HOWL dipped 15.9% to close at $6.02.
• BigCommerce Holdings, Inc. BIGC fell 15.6% to close at $21.85 after the company reported worse-than-expected Q4 adjusted EPS results and issued guidance.
• Kyndryl Holdings, Inc. KD dropped 14.8% to close at $13.50 after the company reported Q4 earnings results and said it sees Q1 sales down roughly 5%.
• Ranpak Holdings Corp. PACK fell 14.8% to close at $20.61.
• Ranpak recently reported Q4 earnings results.
• Amylyx Pharmaceuticals, Inc. AMLX dropped 14.8% to close at $28.04.
• eHealth, Inc. EHTH fell 14.6% to close at $13.27 after the company reported worse-than-expected Q4 sales results.
• Shift Technologies, Inc. SFT dropped 14.4% to close at $1.73.
• CSP Inc. CSPI fell 14.3% to close at $7.07.
• International Game Technology PLC IGT dropped 13.9% to close at $26.37 following Q4 results.
• Lucid Group, Inc. LCID fell 13.8% to close at $24.99 after the company reported worse-than-expected Q4 sales results and cut FY22 production guidance.
• ON24, Inc. ONTF dipped 12.4% to close at $13.67 after the company issued Q1 and FY22 guidance below analyst estimates.
• Groupon, Inc. GRPN shares fell 7.7% to close at $20.05 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.

Also check this out: Eli Lilly And 3 Other Stocks Sold By Insiders.